A Randomized Controlled Trial of Diabetes Screening Immediately Postpartum (DIP) and Follow Up PP CARE | MicrobiomeTrials← Back to trialsNCT05909046
A Randomized Controlled Trial of Diabetes Screening Immediately Postpartum (DIP) and Follow Up PP CARE
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2023-07-24Est. Completion: 2026-06-30
Enrollment target: 104 participants Locations- The Ohio State University Wexner Medical Center OB/GYN Maternal and Fetal Medicine, Columbus, Ohio, United States
Other microbiome trials you might be interested in
Gestational DiabetesHypertensive Disorder of Pregnancy
Hypertensive disorders during pregnancy (HDP) and gestational diabetes (GDM) are among the leading complications in preg…
Multiple LocationsEst. completion Feb 28, 2030
Maternal ComplicationsPregnancy ComplicationBirth Outcomes, AdversePregnancy
The purpose of this study is to evaluate pregnancy-related health outcomes in participants who are exposed to Epidiolex/…
Morgantown, United StatesEst. completion Aug 31, 2033
Pre-eclampsiaGestational Diabetes Mellitus (GDM)Fetal Growth Restriction (FGR)Pregnancy Induced Hypertension (PIH)PlacentaPregnancy
Pre-eclampsia (PET) is a condition characterised by high blood pressure and damage to other organs, and is a leading cau…
Oxford, United KingdomEst. completion May 31, 2030